As the average cost of development of an mHealth app increases to $425,000, Markus Pohl from Research2Guidance breaks down where this money goes… more


An expensive cholesterol drug, evolocumab, which is prescribed on the NHS, is claimed to do nothing to prevent fatal heart attacks and strokes and a coalition of doctors have called for it to be withdrawn from use. more


CPhI Worldwide Annual Industry Report member and president of EPCOT International, Girish Malhotra, has stated that if ANDA approval time is reduced from ten to three months the cost of drugs will be lowered. more


With the average cost of getting a novel drug to market at almost £1.6bn ($2.5bn) deal-making is becoming vital for pharmaceutical companies to offset rising Research and Development (R&D) costs, according to GBI Research more